NCT05675319 2026-01-05AlloRelapseMMUniversitätsklinikum Hamburg-EppendorfPhase 3 Terminated28 enrolled
NCT03769181 2025-09-23A Study of Isatuximab-based Therapy in Participants With LymphomaSanofiPhase 1/2 Terminated58 enrolled 37 charts